1. Hematology Department and Hematopoietic Cell Transplantation Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;
2. Division of Molecular Oncology and Department of Onco-Hematology, Universita Vita-Salute San Raffaele and Istituto Scientifico San Raffaele, Milan, Italy;
3. Department of Immunology, Mayo Clinic, Rochester, MN;
4. Haematological Malignancy Diagnostic Service, St. James’s Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom;
5. Centro de Investigación del Cáncer and Department of Medicine, University of Salamanca, Salamanca, Spain;
6. Department of Medicine, Duke University Medical Center, Durham, NC;
7. Department of Medical Sciences, Hematology 1 Centro Trapianti di Midollo Osseo University of Milan, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy;
8. Rete Ematologica Lombarda, Milan, Italy;
9. Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy;
10. Niguarda Ca’ Granda Hospital, Milan, Italy; and
11. Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece